SU M M A R Y Two patients are described in whom computerised tomography revealed contrastenhanced lesions in the early stages of multiple sclerosis. Such lesions may be differentiated from tumours by their transient nature, lack of space-occupying effect, and localisation in the white matter. Contrast enhancement in demyelinating disease is probably related to local breakdown of the blood-brain barrier.
Recent publications (Cala and Mastaglia, 1976; Gyldensted, 1976a, b; Jacobs and Kinkel, 1976; Wuthrich et al., 1976) have described a high incidence of abnormal computerised tomography (CT) scans in patients with multiple sclerosis. Low attenuation lesions situated mainly in the white matter, ventricular dilatation with irregular edges, and enlarged sulci are the most frequent findings. Contrast enhancement of demyelinating lesions appears to be rare; Wuthrich et al. (1976) reported one case in a series of 60 patients, and there is only one other in the literature (Cole and Ross, 1977) . Both patients were diagnosed as having multiple sclerosis on clinical grounds. We describe two further patients with contrast-enhanced lesions in whom a definite diagnosis of demyelinating disease could not be made at the time of scanning, either clinically or with the aid of cerebrospinal fluid (CSF) examination and visual evoked potentials. In both cases the subsequent clinical course pointed to "clinically definite" multiple sclerosis (McDonald, 1975) (Fig. 2) .
The patient's speech disturbance resolved within a few days, and her ataxia improved gradually over a period of two months. A 31 year old right handed woman was admitted to the National Hospital with a two month history of darkening of vision on the right side of her visual fields. One week before admission she had developed word finding difficulties. At the same time she had noticed problems with reading because of lack of understanding, and tended to spell incorrectly and to make simple grammatical errors 'when writing. She had taken an oral contraceptive pill for seven years until one month before admission.
On examination she had a moderate expressive and nominal dysphasia. Dressing was apraxic. She had mild dyscalculia, dyslexia, dysgraphia, and right-left disorientation but no finger agnosia. There was a dense right homonymous hemianopia with macular sparing. She had right facial weakness and mild right sided pyramidal type weakness in the limbs. Reflexes, co-ordination, and sensation were normal. General examination was negative.
Routine haematology and biochemistry were normal and serological tests for syphilis negative. The CSF contained one mononuclear cell per mm3, protein 0.65 g/l, IgG 9.5%. Visual evoked potentials were grossly asymmetrical but not delayed. Gamma scan showed two areas of increased uptake in the left frontal and temporal regions. The CT scan showed a low attenuation (12 EMI units) area adjacent to the wall of the left lateral ventricle (Fig. 3a) . After intravenous sodium iothalamate dense, ill-defined enhancement of four areas around the lateral ventricles was seen (Fig. 3b) . Carotid angiography confirmed the presence of ventricular dilatation but no other lesion was seen.
The patient was thought to have multiple cerebral metastases but intensive investigation failed to establish a primary lesion. During admission her dysphasia improved considerably. Three weeks Fig. 3 (Figs. 4a, b) .
The patient was treated with ACTH and discharged two months later, having recovered bladder function. She was able to walk but was still moderately ataxic.
Discussion
In the two patients described, the initial diagnosis was not that of demyelinating disease, although the subsequent relapsing and remitting course with the development of typical visual evoked potentials and oligoclonal gamma globulin bands on CSF electrophoresis (Link and Muller, 1971) pointed to "clinically definite" multiple sclerosis (McDonald, 1975) in both cases. The first patient was thought to have a vascular cause for her hemiplegia at the time of presentation, probably related to the oral contraceptive pill. The recurrence one year later, together with the CT scan appearance, was highly suggestive of a tumour. Biopsy of the lesion would almost certainly have been undertaken had it not been in the dominant hemisphere. The second patient, unlike the first, had clinical evidence of multiple neurological lesions on her first admission and could be categorised as "progressive probable" multiple sclerosis (McDonald, 1975 It would seem that in these cases, and those described in this paper, the enhancing lesions were acute. This supposition is supported by the postmortem findings described by Wuthrich et al.
(1976).
Clearly, not all recent demyelinating lesions cause contrast enhancement on CT scanning; if this were the case it would be a relatively common finding as scans tend to be performed for diagnostic purposes on patients with active neurological disease. Enhancement may well be a transient phenomenon during the evolution of such lesions. The mechanism of contrast enhancement in areas of demyelination is uncertain. Contrast enhancement has two different components which may be seen alone but are combined in most instances; one is intravascular, as seen in angiomas and large aneurysms, whereas the extravascular component is due to breakdown of the blood-brain barrier (Gado et al., 1975) and is seen in the acute phase of infarction. Broman (1964) demonstrated blood-brain barrier damage in multiple sclerosis by perfusing brains after death with trypan blue. It is not clear whether there was any relationship between the extent of the bloodbrain barrier damage and the age of the plaques. Lumsden (1970) commented on the discontinuity of demyelinating plaques around veins in recent lesions and suggested that this finding may be related to disturbed blood-brain barrier function. The nature of this dysfunction remains uncertain because of the paucity of ultrastructural studies on acute multiple sclerosis. Since an intravascular component of enhancement can be excluded in demyelinating disease, it must be caused by changes in the blood-brain barrier. 
